NUDT5 and breast carcinoma: IHC of 30 paired breast cancer tissues at different pathological stages found that 100% of the para-cancer tissues (N = 30) had low NUDT5 expression, while 22 tumor tissues (73.33%) had high-expression of the NUDT5 (Student’s t-test; P < 0.001).